Skip to main content
Journal of Refractive Surgery, 2011;27(7):482–487
Cite this articlePublished Online:https://doi.org/10.3928/1081597X-20101223-02Cited by:52

Abstract

PURPOSE:

To evaluate the safety, efficacy, and stability of the Artiflex (Ophtec BV) foldable anterior iris-claw phakic intraocular lens (PIOL) following corneal collagen cross-linking (CXL) in select cases of progressive keratoconus.

METHODS:

This prospective, comparative study, conducted between March 2007 and June 2008, involved 11 eyes with progressive keratoconus. Inclusion criteria were progressive keratoconus (Amsler-Krumeich classification grades I and II) with no corneal opacities, corneal thickness >450 μm, endothelial cell count >2500 cells/mm2, anterior chamber depth >3.2 mm, spherical equivalent refraction >4.50 diopters (D) (with a cylinder component <2.00 D), and no other treatment for keratoconus other than contact lens. Each patient underwent CXL in the keratoconic eye with implantation of the Artiflex IOL 6 months thereafter. Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and refraction and topographic profiles were examined at 1, 6, and 12 months after the CXL procedure.

RESULTS:

All eyes achieved UDVA of 0.3 logMAR or better. Final spherical and cylindrical error ranged from 0 to −1.50 D and 0 to −1.75 D, respectively. No eyes lost lines of preoperative CDVA. Statistically significant reductions in mean maximum (2.14 D, P<.001) and minimum (1.17 D, P=.02) keratometry values were present 12 months after the CXL procedure. No complications were observed.

CONCLUSIONS:

Combined CXL and Artiflex implantation was a safe and effective treatment in this subset of eyes with progressive keratoconus. Good results in terms of visual acuity, postoperative residual refractive error, and keratometry values were identified.

  • 1.Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998; 42(4):297–319.10.1016/S0039-6257(97)00119-7

    > Crossref MedlineGoogle Scholar
  • 2.Cannon DJ, Foster CS. Collagen crosslinking in keratoconus. Invest Ophthalmol Vis Sci. 1978; 17(1):63–65.

    > MedlineGoogle Scholar
  • 3.Seiler T, Hafezi F. Corneal cross-linking-induced stromal demarcation line. Cornea. 2006; 25(9):1057–1059.10.1097/01.ico.0000225720.38748.58

    > Crossref MedlineGoogle Scholar
  • 4.Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res. 1998; 66(1):97–103.10.1006/exer.1997.0410

    > Crossref MedlineGoogle Scholar
  • 5.Kohlhaas M, Spoerl E, Schilde T, Unger G, Wittig C, Pillunat LE. Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet A light. J Cataract Refract Surg. 2006; 32(2):279–283.10.1016/j.jcrs.2005.12.092

    > Crossref MedlineGoogle Scholar
  • 6.Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg. 2003; 29(9):1780–1785.10.1016/S0886-3350(03)00407-3

    > Crossref MedlineGoogle Scholar
  • 7.Wollensak G, Wilsch M, Spoerl E, Seiler T. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/UVA. Cornea. 2004; 23(5):503–507.10.1097/01.ico.0000105827.85025.7f

    > Crossref MedlineGoogle Scholar
  • 8.Spoerl E, Wollensak G, Seiler T. Increased resistance of cross-linked cornea against enzymatic digestion. Curr Eye Res. 2004; 29(1):35–40.10.1080/02713680490513182

    > Crossref MedlineGoogle Scholar
  • 9.Wollensak G, Aurich H, Pham DT, Wirbelauer C. Hydration behavior of porcine cornea crosslinked with riboflavin and ultraviolet A. J Cataract Refract Surg. 2007; 33(3):516–521.10.1016/j.jcrs.2006.11.015

    > Crossref MedlineGoogle Scholar
  • 10.Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg. 2009; 35(8):1358–1362.10.1016/j.jcrs.2009.03.035

    > Crossref MedlineGoogle Scholar
  • 11.Coskunseven E, Jankov MR, Hafezi F. Contralateral eye study of corneal collagen cross-linking with riboflavin and UVA irradiation in patients with keratoconus. J Refract Surg. 2009; 25(4):371–376.10.3928/1081597X-20090401-02

    > LinkGoogle Scholar
  • 12.Grewal DS, Brar GS, Jain R, Sood V, Singla M, Grewal SP. Corneal collagen crosslinking using riboflavin and ultraviolet-A light for keratoconus: one-year analysis using Scheimpflug imaging. J Cataract Refract Surg. 2009; 35(3):425–432.10.1016/j.jcrs.2008.11.046

    > Crossref MedlineGoogle Scholar
  • 13.Moshirfar M, Holz HA, Davis DK. Two-year follow-up of the Artisan/Verisyse iris-supported phakic intraocular lens for the correction of high myopia. J Cataract Refract Surg. 2007; 33(8):1392–1397.10.1016/j.jcrs.2007.04.009

    > Crossref MedlineGoogle Scholar
  • 14.Dick HB, Budo C, Malecaze F, Güell JL, Marinho AA, Nuijts RM, Luyten GP, Menezo JL, Kohnen T. Foldable Artiflex phakic intraocular lens for the correction of myopia: two-year follow-up results of a prospective European multicenter study. Ophthalmology. 2009; 116(4):671–677.10.1016/j.ophtha.2008.12.059

    > Crossref MedlineGoogle Scholar
  • 15.Tahzib NG, Nuijts RM, Wu WY, Budo CJ. Long-term study of Artisan phakic intraocular lens implantation for the correction of moderate to high myopia: ten-year follow-up results. Ophthalmology. 2007; 114(6):1133–1142.10.1016/j.ophtha.2006.09.029

    > Crossref MedlineGoogle Scholar
  • 16.Güell JL, Morral M, Gris O, Gaytan J, Sisquella M, Manero F. Five-year follow-up of 399 phakic Artisan-Verisyse implantation for myopia, hyperopia, and/or astigmatism. Ophthalmology. 2008; 115(6):1002–1012.10.1016/j.ophtha.2007.08.022

    > Crossref MedlineGoogle Scholar
  • 17.Stulting RD, John ME, Maloney RK, Assil KK, Arrowsmith PN, Thompson VMU.S. Verisyse Study Group. Three-year results of Artisan/Verisyse phakic intraocular lens implantation. Results of the United States Food And Drug Administration clinical trial. Ophthalmology. 2008; 115(3):464–472.e1.10.1016/j.ophtha.2007.08.039

    > Crossref MedlineGoogle Scholar
  • 18.Caporossi A, Baiocchi S, Mazzotta C, Traversi C, Caparossi T. Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study. J Cataract Refract Surg. 2006; 32(5):837–845.10.1016/j.jcrs.2006.01.091

    > Crossref MedlineGoogle Scholar
  • 19.Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003; 135(5):620–627.10.1016/S0002-9394(02)02220-1

    > Crossref MedlineGoogle Scholar
  • 20.Raiskup-Wolf F, Hoyer A, Spoerl E, Pillunat LE. Collagen cross-linking with riboflavin and ultraviolet-A light in keratoconus: long term results. J Cataract Refract Surg. 2008; 34(5):796–801.10.1016/j.jcrs.2007.12.039

    > Crossref MedlineGoogle Scholar
  • 21.Wittig-Silva C, Whiting M, Lamoureux E, Lindsay RG, Sullivan LJ, Snibson GR. A randomized controlled trial of corneal collagen crosslinking in progressive keratoconus: preliminary results. J Refract Surg. 2008; 24(7):S720–S725.

    > MedlineGoogle Scholar
  • 22.Güell JL, Velasco F, Malecaze F, Vasquez M, Gris O, Manero F. Secondary Artisan-Verysise aphakic lens implantation. J Cataract Refract Surg. 2005; 31(12):2266–2271.10.1016/j.jcrs.2005.06.047

    > Crossref MedlineGoogle Scholar
  • 23.Güell JL, Vazquez M, Malecaze F, Manero F, Gris O, Velasco F, Hulin H, Pujol J. Artisan toric phakic intraocular lens for the correction of high astigmatism. Am J Ophthalmol. 2003; 136(3):442–447.10.1016/S0002-9394(03)00295-2

    > Crossref MedlineGoogle Scholar
  • 24.Budo C, Bartels MC, van Rij G. Implantation of Artisan toric phakic intraocular lenses for the correction of astigmatism and spherical errors in patients with keratoconus. J Refract Surg. 2005; 21(3):218–222.

    > LinkGoogle Scholar
  • 25.Venter J. Artisan phakic intraocular lens in patients with keratoconus. J Refract Surg. 2009; 25(9):759–764.10.3928/1081597X-20090813-01

    > LinkGoogle Scholar
  • 26.Maloney RK, Nguyen LH, John ME. Artisan phakic intraocular lens for myopia: short-term results of a prospective, multicenter study. Ophthalmology. 2002; 109(9):1631–1641.10.1016/S0161-6420(02)01170-3

    > Crossref MedlineGoogle Scholar
  • 27.Budo C, Hessloehl JC, Izak M, Luyten GP, Menezo JL, Sener BA, Tassignon MJ, Termote H, Worst JG. Multicenter study of the Artisan phakic intraocular lens. J Cataract Refract Surg. 2000; 26(8):1163–1171.10.1016/S0886-3350(00)00545-9

    > Crossref MedlineGoogle Scholar
  • 28.Benedetti S, Casamenti V, Marcaccio L, Brogioni C, Assetto V. Correction of myopia of 7 to 24 diopters with the Artisan phakic intraocular lens: two year follow-up. J Refract Surg. 2005; 21(2):116–126.

    > LinkGoogle Scholar
  • 29.Bourne WM, Nelson LR, Hodge DO. Central corneal endothelial cell changes over a ten-year period. Invest Ophthalmol Vis Sci. 1997; 38(3):779–782.

    > MedlineGoogle Scholar
  • 30.Menezo JL, Cisneros AL, Rodriguez-Salvator V. Endothelial study of iris-claw phakic lens: four year follow-up. J Cataract Refract Surg. 1998; 24(8):1039–1049.

    > Crossref MedlineGoogle Scholar
  • 31.Landesz M, Worst JG, van Rij G. Long-term results of correction of high myopia with an iris claw phakic intraocular lens. J Refract Surg. 2000; 16(3):310–316.

    > LinkGoogle Scholar
  • 32.Kamburoglu G, Ertan A, Bahadir M. Implantation of Artisan toric phakic intraocular lens following Intacs in a patient with keratoconus. J Cataract Refract Surg. 2007; 33(3):528–530.10.1016/j.jcrs.2006.10.047

    > Crossref MedlineGoogle Scholar

We use cookies on this site to enhance your user experience. For a complete overview of all the cookies used, please see our privacy policy.

×